Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Uhlin

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Transplant Immunology|September 21, 2011
WITHDRAWN: Treatment with mesenchymal stromal cells does not improve long-term survival in patients with severe acute GVHDMats Remberger, Michael Uhlin, Helen Karlsson, et al.
Expert Review of Clinical Immunology|April 6, 2013
Systems level immune response analysis and personalized medicinePetter Brodin, Davide Valentini, Michael Uhlin, et al.
Cytotherapy|June 4, 2018
Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor T cellsRehab Alnabhan, Ahmed Gaballa, Lisa-Mari Mörk, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 10, 2018
CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN-γ Production ProfileIsabelle Magalhaes, Ingrid Kalland, James N Kochenderfer, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2009
A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantationMichael Uhlin, Mantas Okas, Jens Gertow, et al.
Clinical Immunology (Orlando, Fla.)|March 6, 2012
Expansion of T-cells from the cord blood graft as a predictive tool for complications and outcome of cord blood transplantationJens Gertow, Sofia Berglund, Mantas Okas, et al.
Scandinavian Journal of Immunology|February 25, 2022
SARS-CoV-2 (COVID-19)-specific T cell and B cell responses in convalescent rheumatoid arthritis: Monozygotic twins pair case observationLucas C M Arruda, Ahmed Gaballa, Rui Da Silva Rodrigues, et al.
Transfusion|May 14, 2015
Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantationEmma Watz, Mats Remberger, Olle Ringden, et al.
International Journal of Molecular Sciences|October 12, 2016
T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical OutcomeAhmed Gaballa, Mikael Sundin, Arwen Stikvoort, et al.
Clinical Transplantation|May 17, 2017
No effect of HLA-C mismatch after allogeneic hematopoietic stem cell transplantation with unrelated donors and T-cell depletion in patients with hematological malignanciesIsabelle Magalhaes, Michael Uhlin, Marie Schaffer, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Transplant Immunology|September 21, 2011
WITHDRAWN: Treatment with mesenchymal stromal cells does not improve long-term survival in patients with severe acute GVHDMats Remberger, Michael Uhlin, Helen Karlsson, et al.
Expert Review of Clinical Immunology|April 6, 2013
Systems level immune response analysis and personalized medicinePetter Brodin, Davide Valentini, Michael Uhlin, et al.
Cytotherapy|June 4, 2018
Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor T cellsRehab Alnabhan, Ahmed Gaballa, Lisa-Mari Mörk, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 10, 2018
CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN-γ Production ProfileIsabelle Magalhaes, Ingrid Kalland, James N Kochenderfer, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2009
A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantationMichael Uhlin, Mantas Okas, Jens Gertow, et al.
Clinical Immunology (Orlando, Fla.)|March 6, 2012
Expansion of T-cells from the cord blood graft as a predictive tool for complications and outcome of cord blood transplantationJens Gertow, Sofia Berglund, Mantas Okas, et al.
Scandinavian Journal of Immunology|February 25, 2022
SARS-CoV-2 (COVID-19)-specific T cell and B cell responses in convalescent rheumatoid arthritis: Monozygotic twins pair case observationLucas C M Arruda, Ahmed Gaballa, Rui Da Silva Rodrigues, et al.
Transfusion|May 14, 2015
Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantationEmma Watz, Mats Remberger, Olle Ringden, et al.
International Journal of Molecular Sciences|October 12, 2016
T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical OutcomeAhmed Gaballa, Mikael Sundin, Arwen Stikvoort, et al.
Clinical Transplantation|May 17, 2017
No effect of HLA-C mismatch after allogeneic hematopoietic stem cell transplantation with unrelated donors and T-cell depletion in patients with hematological malignanciesIsabelle Magalhaes, Michael Uhlin, Marie Schaffer, et al.
Pageof 11